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A calcium-dependent phospholipase 4 with half-maximal activity at approx. 0.7 PM free Caf + has been identified in 
the cytosolic fraction from macrophages. The enzyme eluted as a 70 kDa protein upon gel chromatography and showed 
increased activity after 10 min pretreatment of the cells with 10 nM phorbol myristate acetate. No significant activity 
could be detected in the membrane fraction. The enzyme hydrolyzed arachidonic acid-containing phosphatidylcholine 
and -ethanolamine as well as phosphatidylinositol. The release of arachidonic acid in the in vitro assay was inhibited 
in a dose-dependent manner by nordihydroguaiaretic acid and quercetin that are also potent inhibitors of the mobiliza- 
tion of arachidonic acid in intact macrophages. 
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1. INTRODUCTION 
Macrophages from the mouse peritoneal cavity 
respond to activators of protein kinase C, such as 
phorbol myristate acetate (PMA), by releasing 
prostaglandin E2 [ 1,2], The arachidonic acid used 
is mobilized from phosphatidylinositol by enhance- 
ment of a phospholipase A pathway that may also 
be responsible for the mobilization from phospha- 
tidylcholine and -ethanolamine [3,4]. However, the 
signal-transducing pathway from kinase C to the 
lipolytic step, as well as the phospholipase en- 
zyme(s) involved, have remained unidentified. We 
have therefore investigated kinase C-dependent 
protein phosphorylation in the macrophages and 
found a close correlation with the release of 
arachidonic acid [5] and have now undertaken to 
identify, isolate and characterize the phospho- 
lipase(s) involved. This paper describes the iden- 
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tification and initial characterization of a soluble, 
calcium-dependent PLA2 activity with an apparent 
molecular mass of approx. 70 kDa. The present 
results strongly suggest hat the enzyme is responsi- 
ble for the kinase C-related mobilization of ara- 
chidonic acid observed in intact macrophages. 
2. EXPERIMENTAL 
Mouse peritoneal macrophages were isolated and cultured 
(2 x lo6 cells/35 mm dish) as described [3]. Cells were scraped 
off the dishes and homogenized in a buffer consisting of 80 mM 
KCI, 5 mM dithioerythritol, 1 mM EDTA and 10 mM Hepes, 
pH 7.4 (buffer A). The homogenate from 12 dishes was cen- 
trifuged at 700 x g for 5 min and the resulting supernatant was 
further centrifuged at lo5 xg for 60 min to obtain a cytosohc 
fraction and a membrane pellet. The cytosolic fraction was then 
run on a column (1 x 48 cm) of either Sephadex G-200 superfine 
or Sephacryl S-300 HR (LKB-Pharmacia), equilibrated in buf- 
fer A containing 10% (v/v) glycerol. 
Assays for PLAz contained 100 pmol phospholipid (5-15 x 
lo3 dpm), solubilized by sonication for 8 min, enzyme (30-60 
~1). CaCla (625 nmol total, 29O/cM free Ca2+) and fatty acid- 
depleted bovine serum albumin (lOO#g) in a total volume of 525 
gl buffer A (without dithioerythritol). Labeled phospholipids 
(Amersham) were; I-stearoyl-2-[3H]arachidonoylphosphatidyl- 
choline (117 Ci/mmol), I-acyl-2-(‘4C]arachidonoylphospha- 
tidylethanolamine (58 mCi/mmol), I-stearoyl-2-[%]arachi- 
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donoylphosphatidylinositol (58 mCi/mmol) and I-palmitoyl-2- 
[‘4C]oleoylphosphatidylcholine (52 mCi/mmol). Nonlabeled 
phospholipids were from Sigma. When the concentration of 
calcium was varied, the concentration of free Ca*+ (in the range 
0. I-20pM) was determined in an SLM 8000 C fluorimeter (SLM 
Instruments) in parallel incubation mixtures also containing 0.1 
pM fura- (Molecular Probes, Eugene, OR), by the use of dual- 
wavelength excitation (at 340 and 380 nm), the fluorescence 
ratio at 492 nm and a Kd for Ca’+ of 135 nM [6]. 
After incubation for 30 min at 37°C the reaction was stopped 
by the addition of 0.1 ml of 250 mM HCl and carrier lipids 
followed by extraction according to Bligh and Dyer. Lipid ex- 
tracts were separated by TLC in a solvent system of diethyl 
ether/light petroleum (b.p. 406O”C)/acetic acid (50:50:2, by 
vol.) and radioactivity in areas corresponding to free fatty acids 
and phospholipids was determined. In later experiments the 
TLC analysis was replaced by a simplified method that gave 
identical results. The lipid phase was then applied to a column 
containing 100 mg silicic acid equilibrated in chloroform. Fatty 
acids were eluted with 1 ml chloroform and phospholipids with 
2.5 ml methanol. In order to assess the formation of radiola- 
beled lysophosphatidylcholine, samples were analyzed by TLC, 
using as solvent chloroform/methanol/4 M NH40H (65 : 35 : 5, 
by vol.). Nordihydroguaiaretic acid, quercetin, taxifolin and p- 
bromophenacylbromide (Sigma) were dissolved in ethanol/H20 
(I 
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Fig. 1. Gel chromatography of the cytosolic fraction from mouse macrophages. Cytosolic fractions were run on Sephadex G-200 and 
60 pl of each fraction was assayed for PLA2 activity using 1-stearoyl-2-l’H]arachidonoylphosphatidylchohne as substrate. Cells 
pretreated with 10 nM PMA for 10 min (0) were compared to control cells (0). There was no difference in protein concentration, as 
determined by A280. The void volume of the column (13.5 ml) was determined using Blue dextran 2000. For further details see text. 
(Inset) Kav of PLA2 compared to standard proteins [immunoglobulin G (150 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa) 
and soybean trypsin inhibitor (20 kDa)]. 
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phatidylcholine without detectable formation of 
labeled lysophosphatidylcholine and (ii) the use of 
phosphatidyl[3H]choline from macrophages as 
substrate yielded labeled lysophosphatidylcholine 
as product (not shown). Furthermore, the presence 
of deoxycholate (50pg/ml) and albumin (4 mg/ml) 
in the assay mixture at concentrations shown 
previously to inhibit severely lysophospholipase [7] 
caused no inhibition of the present enzyme activity. 
When the unfractionated cytosol was assayed for 
PLA2 activity the arachidonic acid released was, to 
a large extent, further metabolized to more polar 
metabolites. Attempts to identify any PLA2 activi- 
ty in the membrane fraction, with or without 
sonication or treatment with detergent, have not 
been successful. 
The PLA2 identified here was totally dependent 
on calcium (fig.2), showed significant activity at 
350 nM free Ca2+ and was fully activated at 
micromolar concentrations, since no further in- 
crease in activity occurred at 1 mM (fig.2) or 5 mM 
Ca2+ (not shown). We have not been able to detect 
any difference in calcium dependence between en- 
zyme from control and PMA-treated cells. The pH 
dependence of the PLA2 activity was also deter- 
mined and a broad optimum was found between 
pH 7 and at least 10, while the activity dropped 
drastically when pH was reduced below 6 (fig.3). 
The drop at acidic pH could, at least in part, be due 
to irreversible loss of activity, since preincubation 
for 15 min at pH 5, in contrast to pH 7.4, resulted 
in considerable loss of activity. The stability of the 
enzyme depended on the presence of glycerol also 
at neutral pH. When the cytosolic fraction was 
stored at 4°C in the presence of 10% glycerol (pH 
7.4) the enzyme retained considerable activity for 
at least 1 month. 
The enzyme was found to hydrolyze arachidonic 
acid-containing phosphatidylcholine and phos- 
phatidylethanolamine qually well (table 1). The 
hydrolysis of arachidonic acid-containing phos- 
phatidylinositol dependend on how this substrate 
was presented. Pure phosphatidylinositol vesicles 
were not hydrolyzed at all, but when 75 mol% 
phosphatidylcholine or -ethanolamine was includ- 
ed, the hydrolysis of phosphatidylinositol was only 
EDTA 
MlMl FREE [Ca"] (EM) 
Fig.2. Calcium dependence of macrophage PLAr. PLAz activity against l-stearoyl-2-[3H]arachidonoylphosphatidylcholine was
measured with enzyme taken through gel chromatography (fig.1) in the presence of various concentrations of free Ca*+. The 
concentration of free Ca’+ in the EDTA-buffered incubation mixtures was determined using the fluorescent probe fura- (see section 
2). Results obtained with different preparations of PLAz are expressed as percent of the activity at 29OrM Ca” (IO-15% hydrolysis) 
and represent means * SD (nr2). 
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Fig.3. pH dependence of the PLA 2 activity. Enzyme from gel chromatography was assayed for PLAl activity vs 
1-stearoyl-2-[‘H]arachidonoylphosphatidylcholine at the pH values shown. Results are expressed as percent of maximal activity and 
represent means k SD (nr3), except at pH 5.2, 5.7 and 6.1 which represent single observations. 
somewhat lower than that of phosphatidylcholine 
(table 1). It should be mentioned that in a mixture 
of 25 mol% phosphatidylcholine and 75 mol% 
phosphatidylinositol the hydrolysis not only of 
phosphatidylinositol but also of phosphatidyl- 
choline was severely inhibited (not shown). We feel 
confident that the hydrolysis of labeled arachidon- 
oylphosphatidylinositol is due to the PLAz rather 
than to phosphoinositide phospholipase C, since 
arachidonic acid was released rather than diacyl- 
Table 1 
Substrate specificity of macrophage PLAl 
Substrate Hydrolysis 
20:4-PC 20:4-PE 20:4-PI 18: I-PC 
20 : 4-PW20: 4-PEa 25.0 31.7 
20 : 4-PC/20 : 4-PIb 27.7 19.1 
20:4-PC/l8: I-PC’ 25.0 7.0 
“l-StearoyI-2-[3H]arachidonoylphosphatidylcholine/l-acyl-2- 
[‘4C]arachidonoylphosphatidylethanolamine (50: 50, mol 070). 
bl-StearoyI-2-[3H]arachidonoyIphosphatidylcholine/l-steaoryl- 
2- [“k]arachidonoylphosphatidylinositol (75: 25, mol%). 
Cl-Stearoyl-2-[3H]arachidonoylphosphatidylcholine/l-palm~to- 
yl-2- [‘4C]oleoylphosphatidylcholine (50: 50, mol @IO). 
(see m.s.) 
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glycerol and the activity against phosphatidyl- 
inositol and -choline coeluted exactly during gel 
chromatography. Furthermore, the activity vs both 
phospholipids was increased to the same extent by 
pretreatment of cells with PMA. It is also clear 
from table 1 that the PLAz enzyme showed a high 
preference for arachidonic acid-compared to oleic 
acid-containing phosphatidylcholine. Omission of 
albumin from the standard assay mixture reduced 
the hydrolysis of arachidonoylphosphatidylcholine 
by 20-40%, most likely because of inhibition by 
reaction products. 
The enzyme was inhibited in a dose-dependent 
manner by nordihydroguaiaretic acid (fig.4A), an 
agent known to inhibit the release of arachidonic 
acid metabolites from macrophages [8] and by the 
flavonoid quercetin, but not by the structurally 
related flavonoid taxifolin (fig.4B). The latter 
result argues against a non-specific inhibitory ef- 
fect of quercetin, such as interaction with the 
phospholipidsubstrate.p-Bromophenacylbromide, 
a well known but far from specific inhibitor of 
PLA2, also inhibited the enzyme in a dose- 
dependent manner with half-maximal effect at 15 
PM (not shown). 
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Fig.4. Effect of inbibitors on macrophage PLAz. Enzyme purified by gel chromatography was assayed against 1-stearoyl-2-[-‘HI- 
arachidonoylphosphatidylcholine i  the presence of various concentrations of inhibitor. Results (from 22 separate xperiments) are 
expressed as percent of control (without inhibitor). (a) Nordihydroguaiaretic acid (NDGA) and (b) quercetin and taxifolin. 
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4. DISCUSSION 
It has been demonstrated earlier that treatment 
of macrophages with PMA or other agents that 
cause activation of protein kinase C [5] induces 
release of arachidonic acid from phosphatidyl- 
choline, -ethanolamine and -inositol [3,4]. Here, 
we have identified a cytosolic PLA2 that releases 
arachidonic acid from all three of these phospho- 
lipids and whose activity is increased after treat- 
ment of the cells with PMA. The enzyme has an ap- 
parent molecular mass of 70 kDa and is the only 
detectable enzyme activity in macrophage homo- 
genate that releases arachidonic acid from phos- 
phatidylcholine under our assay conditions. It is 
therefore likely that investigations on homogenate 
of the same cell type [9] or homogenate and soluble 
fraction of bone marrow-derived mouse macro- 
phages [7] deal with the same 70 kDa PLA2. This 
suggestion is supported in particular by the simi- 
larities in substrate specificity, with activity against 
both phosphatidylcholine and -ethanolamine [7,9] 
and the preference for arachidonoyl over oleoyl- 
phosphatidylcholine [7]. Preferential hydrolysis of 
arachidonoylphosphatidylcholine has also been 
clearly indicated from substrate competition ex- 
periments for the PLAz activity in the cytosol of 
human neutrophils [lo]. Furthermore, an increase 
in PLAz activity in response to PMA treatment, as 
shown here, has been observed in bone marrow- 
derived macrophages by assay on homogenates 
[ll] although treatment for at least 30 min was 
reported to be necessary. 
The calcium dependence of the 70 kDa PLA2, 
with half-maximal activation at approx. 0.7 PM 
free Ca’+, indicates potential regulation by cal- 
cium-mobilizing ligands and is fully consistent with 
the previous finding [5] that calcium ionophores 
also cause liberation of arachidonic acid in intact 
macrophages after down-regulation of protein 
kinase C. 
The inhibition of the enzyme by nordihydrogu- 
aiaretic acid and quercetin showed dose depen- 
dences that were remarkably similar to those for 
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the release of arachidonic acid in intact cells (IGO 
values 2 and 10 ,,YM, respectively in the latter 
system; Emilsson, A. and Sundler, R. unpublish- 
ed), while taxifolin was ineffective in both systems. 
Nordihydroguaiaretic acid and quercetin have also 
been shown to inhibit the PLAz activity in acid ex- 
tracts and sonicates of rabbit neutrophils, although 
with somewhat higher ICSO values [12]. 
In conclusion, the results indicate that the 70 
kDa PLA2 is likely to be responsible for stimulus- 
induced mobilization of arachidonic acid in mouse 
macrophages. Since the same, or a closely related, 
enzyme is also present in various solid organs, it is 
now being purified and further characterised from 
such sources. 
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